SEARCH

SEARCH BY CITATION

References

  • Aguilar-Santelises, M., Amador, J.F., Mellstedt, H. & Jondal, M. (1989) Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-B-CLL). Leukemia Research, 13, 937942.
  • Aguilar-Santelises, M., Loftenius, A., Ljungh, C., Svenson, S.B., Andersson, B., Mellstedt, H. & Jondal, M. (1992) Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis. Leukemia Research, 16, 607613.
  • Aman, P. & Mellstedt, H. (1991) The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (B-CLL) derived cell population. Leukemia Research, 15, 715719.
  • Bassan, R., Buzzetti, M., Marini, B., Rambaldi, A., Allavena, P. & Barbui, T. (1988) Investigation of chronic lymphocytosis in adults. American Journal of Clinical Pathology, 89, 783787.
  • Blattner, W.A., Strober, W., Muchmore, A.V., Blaese, R.M., Broder, S. & Fraumeni, Jr, J.F. (1987) Familial chronic lymphocytic leukemia. Immunologic and cellular characterization. Annals of Internal Medicine, 84, 554557.
  • Byrd, J. (2002) Clonal lymphocytosis of uncertain significance (CLUS): what clues will CLU yield? Blood, 100, 2277.
  • Caporaso, N.E., Whitehouse, J., Bertin, P., Amos, C., Papadopoulos, N., Muller, J., Whang-Peng, J., Tucker, M.A., Fleisher, T.A. & Marti, G.E. (1991) A 20 year clinical and laboratory study of familial B-chronic lymphocytic leukemia in a single kindred. Leukemia & Lymphoma, 3, 331342.
  • Caporaso, N., Fontaine, L., Whitehouse, J. & Marti, G.E. (1997) Familial B-CLL: review of literature and the NCI familial B-CLL registry. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 173180. USPHS, Atlanta, GA.
  • Cartwright, R.A. (1997) Summary of epidemiology and immunobiology. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 215222. USPHS, Atlanta, GA.
  • Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. & Rai, K.R. (1996) National Cancer Institute – sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 49904997.
  • Faguet, G.B., Agee, J.F. & Marti, G.E. (1992) Clone emergence and evolution in chronic lymphocytic leukemia: characterization of clinical, laboratory, and immunophenotypic profiles of 25 patients. Leukemia & Lymphoma, 6, 345356.
  • Fraumeni, Jr, J.F., Vogel, C.L. & DeVita, V.T. (1969) Familial chronic lymphocytic leukemia. Annals of Internal Medicine, 71, 279284.
  • French Cooperative Group on Chronic Lymphocytic Leukemia (1990) Natural history of stage A chronic lymphocytic leukemia untreated patients. British Journal of Haematology, 76, 4557.
  • Garcia, C., Rosen, A., Kimby, E., Aguilar-Santelises, M., Jondal, M., Bjorkhilm, M., Holm, G. & Mellstedt, H. (1989) Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS). Leukemia Research, 13, 3137.
  • Ghia, P., Prato, G., Scielzo, C., Stella, S., Geuna, M., Guida, G. & Caligaris-Cappio, F. (2004) Monoclonal CD5+ and CD5 B lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood, 103, 23372342.
  • Goldin, L.R., Sgambati, M., Marti, G.E., Fontaine, L., Ishibe, N. & Caporaso, N. (1999) Anticipation in familial chronic lymphocytic leukemia. American Journal of Human Genetics, 65, 265269.
  • Hampel, H., Sweet, K., Westman, J.A., Offit, K. & Eng, C. (2004) Referral for cancer genetics consultations: a review and compilation of risk assessment criteria. Journal of Medical Genetics, 41, 8191.
  • Han, T., Ozer, H., Gavigan, M., Gajera, R., Minowada, J., Bloom, M.L., Sadamori, N., Sandberg, A.A., Gomez, G.A. & Henderson, E.S. (1984) Benign monoclonal B cell lymphocytosis – a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood, 64, 244252.
  • Ishibe, N., Sgambati, M.T., Fontaine, L., Goldin, L.R., Jain, N., Weissman, N., Marti, G.E. & Caporaso, N.E. (2001) Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry. Leukemia & Lymphoma, 42, 99108.
  • Ishibe, N., Prieto, D., Hosack, D.A., Lempicki, R.A., Golden, L.R., Raffeld, M., Marti, G.E. & Caporaso, N.E. (2002a) Telomere length and heavy-chain mutation status in familial chronic lymphocytic leukemia. Leukemia Research, 26, 791794.
  • Ishibe, N., Albitar, M., Dilani, I.B., Golden, L.R., Marti, G.E. & Caporaso, N.E. (2002b) CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not. Blood, 100, 11001101.
  • Jack, A., Richards, S., Evans, P. & Wilks, C. (1997) Population screening for B-cell monoclonal lymphocytosis using PCR and flow cytometry to determine immunophenotypes. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 9396. USPHS, Atlanta, GA.
  • Kimby, E., Mellstedt, H., Bjorkholm, M. & Holm, G. (1989) Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and mono-clonal lymphocytosis of undetermined significance. European Journal of Haematolgy, 43, 452459.
  • Kussick, S.J., Kalnoski, M., Braziel, R.M. & Wood, B.L. (2004) Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. American Journal of Clinical Pathology, 121, 464472.
  • Kyle, R.A. & Rajkumar, S.V. (1999) Monoclonal gammopathies of undetermined significance. Hematology/Oncology Clinics of North America, 13, 11811202.
  • Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.F. & Melton, III, L.J. (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 346, 564569.
  • Maiese, R.L. & Braylan, R.C. (1997) Detection of low levels of B-cell lymphoproliferative disorders. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 6168. USPHS, Atlanta, GA.
  • Mandelli, F., De Rossi, G., Mancini, P., Alberti, A., Cajozzo, A., Grignani, F., Leoni, P., Liso, V., Martelli, M., Neri, A., Resegotti, L. & Torlotano, G. (1987) Progression in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group. Journal of Clinical Oncology, 5, 398404.
  • Marti, G.E. (1993) Mechanisms of a B cell neoplasia. In: Workshop at the Basel Institute for Immunology, April 4–6, 1993 organized by Fritz Melchers and Michael Potter (ed. by M.F.Melchers), pp. 129136. Editiones Roche, Basel, Switzerland.
  • Marti, G.E., Faguet, G.B., Stewart, C., Branham, P., Carter, P.H., Washington, G.C., Bertin, P., Muller, J., Zenger, V., Caporaso, N., Whitehouse, J., Amos, C.I., Fleisher, T.A. & Vogt, R. (1992a) Evolution of leukemic heterogeneity of human B-CLL lymphocytes between and within patients. Current Topics in Microbiology and Immunology, 182, 303311.
  • Marti, G.E., Faguet, G., Bertin, P., Agee, J., Washington, G., Ruiz, S., Carter, P., Zenger, V., Vogt, R. & Noguchi, P. (1992b) CD20 and CD5 expression in B-chronic lymphocytic leukemia (B-CLL). Proceedings of the New York Academy of Sciences of the United States of America, 651, 480483.
  • Marti, G.E., Muller, J., Stetler-Stevenson, M. & Caporaso, N. (1997) B-cell monoclonal lymphocytosis in three individuals living near a hazardous waste site. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 3750. USPHS, Atlanta, GA.
  • Marti, G.E., Carter, P., Abbasi, F., Washington, G.C., Jain, N., Zenger, V.E., Ishibe, N., Goldin, L., Fontaine, L., Weissman, N., Sgambati, M., Faguet, G., Bertin, P., Vogt, Jr, R.F., Slade, B., Noguchi, P., Stetler-Stevenson, M.A. & Caporaso, N. (2003) B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry Part B (Clinical Cytometry), 52B, 112.
  • Montserrat, E., Vinolas, N., Reverter, J.C. & Rozman, C. (1988) Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages. Nouvelle Revue Francaise d'Hematologie, 30, 359361.
  • Neuland, C.Y., Blattner, W.A., Mann, D.L., Fraser, M.C., Tsai, S. & Strong, D.M. (1983) Familial chronic lymphocytic leukemia. Journal of the National Cancer Institute, 71, 11431150.
  • O'Connor, S.J.M., Rawstron, A.C., Plummer, M., Hillmen, P., Owen, R.G. & Jack, A.S. (2003) Demonstration of the genotypic relationship between CLUS and clinical B-CLL. Leukemia and Lymphoma, 44(Suppl. 2): S13.
  • Rachel, J.M., Zucker, M.L., Plapp, F.V., Fox, C.M., Marti, G.E., Abbasi, F. & Menitove, J.E. (2002) B cell monoclonal lymphocytosis in blood donors (abstract). Blood, 100, 590a.
  • Rawstron, A.C., Kennedy, B., Evans, P.A., Davies, F.E., Richards, S.J., Haynes, A.P., Russell, N.H., Hale, G., Morgan, G.J., Jack, A.S. & Hillmen, P. (2001) Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood, 98, 2935.
  • Rawstron, A.C., Green, M.J., Kuzmicki, A., Kennedy, B., Fenton, J.A., Evans, P.A., O'Connor, S.J., Richards, S.J., Morgan, G.J., Jack, A.S. & Hillmen, P. (2002a) Monoclonal B lymphocytes with the characteristics of ‘‘indolent’’ chronic lymphocytic leukemia are present in 3·5% of adults with normal blood counts. Blood, 100, 635639.
  • Rawstron, A.C., Yuille, M.R., Fuller, J., Cullen, M., Kennedy, B., Richards, S.J., Jack, A.S., Matutes, E., Catovsky, D., Hillmen, P. & Houlston, R.S. (2002b) Inherited predisposition to CLL is detectable as sub-clinical monoclonal B-lymphocyte expansion. Blood, 100, 22892291.
  • Rawstron, A.C., de Tute, R., O'Connor, S.J.M., Richards, S.J., Jack, A.S. & Hillmen, P. (2003) The natural history of ‘‘early CLL’’. Blood, 102, 188a.
  • Sarasua, S.M., Vogt, R.F., Middleton, D.C., Slade, B.A, McGeehin, M.A. & Lybarger, J.A. (1997) ‘CLL-like’ B-cell phenotypes detected in superfund studies: epidemiologic methods and findings. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 718. USPHS, Atlanta, GA.
  • Slade, B.A. (1999) Follow-up investigation of B-cell abnormalities identified in previous ATSDR health studies: US Department of Health and Human Services. Public Health Service, Publication No. PB99–138331.
  • The International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749757.
  • Vogt, R.F., Meredith, M.N.K., Powell, J., Ethridge, S.F., Whitfield, W., Henderson, L.O. & Hannon, W.H. (1997) Results in eleven individuals with B-CLL-like phenotypes detected in environmental health studies. In: Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B-cell Chronic Lymphocytic Leukemia and Other B-cell Lymphoproliferative Disorders (ed. by G.E.Marti, R.F.Vogt & V.E.Zenger), pp. 1935. USPHS, Atlanta, GA.
  • Wang, C., Amato, D. & Fernandes, B. (2002a) CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS). American Journal of Hematology, 69, 147149.
  • Wang, C., Amato, D., Rabah, R., Zheng, J. & Fernandes, B. (2002b) Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (B-CLL) with weak CD5 expression from CD5- B-CLL. Leukemia Research, 26, 11251129.
  • Yuille, M.R., Matutes, E., Marossy, A., Hilditch, B., Catovsky, D. & Houlston, R.S. (2000) Familial chronic lymphocytic leukemia: a survey and review of the literature. British Journal of Haematology, 109, 794799.